Skip to main content

Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?

Summary

N-Acetylcysteine (NAC) is known to decrease the exacerbation rate in patients with chronic bronchitis. It has also been shown that NAC has both an oxygen-radical scavenger and a heavy-metal chelating effect in high intravenous doses. In a study lasting 5 weeks, 10 healthy volunteers were treated with NAC 200 mg t. d. s. for two weeks. The concentrations of trace metals (Ca, Mg, Fe, Zn & Cu) in plasma were measured weekly and daily in a morning spot urine during the investigation.

No significant change in plasma concentration or excretion was found during the two weeks of treatment, implying that additional administration of trace metals is unnecessary for patients treated perorally with a therapeutic dose of NAC.

This is a preview of subscription content, access via your institution.

References

  1. Sheffner AL (1963) The reduction in vitro in viscosity of muco- protein solutions by a new mucolytic agent, N-Acetylcysteine. Ann NY Acad Sci 106:298–310

    PubMed  CAS  Article  Google Scholar 

  2. Hurst GA, Shaw PB, LeMaistre CA (1967) Laboratory and clini- cal evaluation of the mucolytic properties of acetylcysteine. Am Rev Respir Dis 96: 962–970

    PubMed  CAS  Google Scholar 

  3. Kory RC, Hirsch RS, Giraldo J (1968) Nebulization of N-Ace- tylcysteine combined with a bronchodilator in patients with chronic bronchitis. Dis Chest 54:18–23

    Google Scholar 

  4. Cotgreave IA, Eklund A, Larsson K, Moldéus PW (1987) No penetration of orally administered N-acetylcysteine into bron- choalveolar lavage fluid. Eur J Respir Dis 70:73–77

    PubMed  CAS  Google Scholar 

  5. Jeffery P (1986) Anti-inflammatory drugs and experimental bronchitis. Eur J Respir Dis 69 [Supp1 146]: 245–257

    Google Scholar 

  6. Grassi C, Morandini GC (1976) A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bron- chitis. Eur J Clin Pharmacol 9:393–396

    Article  CAS  Google Scholar 

  7. Boman G, Bficker U, Larsson S, Melander B, Wåhlander L (1983) Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64:405–415

    PubMed  CAS  Google Scholar 

  8. Moldéus P, Cotgrave IA, Berggren M (1986) Lung protection by a thiol-containing antioxidant: N-Acetylcysteine. Respiration 50: [Suppl 1] 31–42

    PubMed  Google Scholar 

  9. Wagner PD, Mathieu-Costello O, Bebout DE, Gray AT, Natter- son PD, Glennow C (1989) Protection against pulmonary O2tox- icity by N-Acetylcysteine. Eur Respir J 2:116–126

    PubMed  CAS  Google Scholar 

  10. Lorber A, Baumgartner WA, Bovy RA, Chang CC, Hollcraft R (1973) Ctincal application for heavy metal-complexing potential of N-Acetylcysteine. J Clin Pharmaco1 13:332–336

    CAS  Google Scholar 

  11. Gofrey NF, Peter A, Simon TM, Lorber A (1982) IV N-Ace- tylcysteine treatment of hematologic reactions to chrysotherapy. JRheumatol 9:519–526

    Google Scholar 

  12. Hjortsr E, Qvist J, Bud MIet al. (1988) ARDS after accidental inhalation of zinc chloride smoke. Int Care Med 27:522–525

    Google Scholar 

  13. Weidner MG, Clowes GHA (1960) The role of the kidney in hy- pocalcemia induced by citrate infusion. Surg Forum 10:444–449

    PubMed  Google Scholar 

  14. Walser M (1961) Ion association. VII. Dependence of calciuresis on natriuresis during sulfate infusion. Am J Physio1 201:769–773

    CAS  Google Scholar 

  15. Olsson B, Johansson M, Gabrielsson J, Bolme P (1988) Pharma- cokinetics and bioavailability of reduced and oxidized N-Ace- tylcysteine. Eur J Clin Pharmaco1 34:77–82

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hjortsrø, E., Fomsgaard, J.S. & Fogh-Andersen, N. Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally? . Eur J Clin Pharmacol 39, 29–31 (1990). https://doi.org/10.1007/BF02657052

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02657052

Key words

  • Acetylcysteine
  • Metal excretion
  • Trace metals
  • NAC